SCHEMBL6988832

SCHEMBL6988832

CS(=O)(=O)c1c(-c2ccccc2)ccc(N2CCCC(NC(=O)c3ccnc(Cl)c3)C2=O)c1F

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 17/20 0.49
F10 P00742 3/20 0.49
FPR1 P21462 13/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985111 0.88 F10 (0.49) FPR2F10FPR1
SCHEMBL6985267 0.88 FPR2 (0.55) FPR2F10FPR1
SCHEMBL6987862 0.87 F10 (0.54) FPR2F10FPR1
SCHEMBL6981073 0.85 F10 (0.56) FPR2F10FPR1
SCHEMBL6988559 0.83 FPR2 (0.50) FPR2F10FPR1
SCHEMBL4680775 0.82 FPR2 (0.72) FPR2F10FPR1
SCHEMBL7090057 0.81 F10 (0.46) FPR2F10FPR1
SCHEMBL28381115 0.80 F10 (0.48) FPR2F10FPR1
SCHEMBL28689753 0.79 FPR2 (0.67) FPR2FPR1
SCHEMBL28382471 0.79 FPR2 (0.67) FPR2FPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP claimed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO claimed